Effects of a single dose of an intranasal feline herpesvirus 1, calicivirus, and panleukopenia vaccine on clinical signs and virus shedding after challenge with virulent feline herpesvirus 1
- PMID: 16442823
- PMCID: PMC10832857
- DOI: 10.1016/j.jfms.2005.12.001
Effects of a single dose of an intranasal feline herpesvirus 1, calicivirus, and panleukopenia vaccine on clinical signs and virus shedding after challenge with virulent feline herpesvirus 1
Abstract
The objective of this study was to determine whether intranasal administration of a commercially available FVRCP vaccine to kittens lessened clinical signs and feline herpesvirus 1 (FHV-1) viral shedding when compared to unvaccinated control kittens after FHV-1 challenge. Three groups of 10 unvaccinated kittens were administered one dose of vaccine 6 days (group 1), 4 days (group 2), or 2 days (group 3) before challenge, respectively. One group was maintained as unvaccinated controls (group 4). FHV-1 challenge was then induced and the kittens were observed for 14 days. When the grouped vaccinated kitten results (groups 1-3) were compared to group 4 results, clinical scores following challenge were significantly lower (P<0.05) and significantly lower body temperatures (P<0.05) were detected on days 0, 5 and 9 post-challenge. When evaluated by individual group, group 1 and group 2 kittens had significantly lower clinical scores (P<0.05) than group 4 kittens post-challenge. In addition, FHV-1 shedding was lower in group 1 kittens when compared to group 4 kittens on day 6 after challenge (P<0.05). Administration of this vaccine within several days prior to exposure lessened clinical signs of disease and FHV-1 shedding compared to unvaccinated kittens.
Figures


References
-
- Binns S.H., Dawson S., Speakman A.J., Cuevas L.E., Hart C.A., Gaskell C.J., Morgan K.L., Gaskell R.M. A study of feline upper respiratory tract disease with reference to prevalence and risk factors for infection with feline calicivirus and feline herpesvirus, Journal of Feline Medicine and Surgery 2, 2000, 123–133. - PMC - PubMed
-
- Burton G., Mason K.V. Do postvaccinal sarcomas occur in Australian kittens?, Australian Veterinary Journal 75, 1997, 102–106. - PubMed
-
- Cocker F.M., Gaskett R.M., Newby T.J., Gaskell C.J., Stokes C.R., Bourne F.J. Efficacy of early (48 and 96 h) protection against feline viral rhinotracheitis following intranasal vaccination with a live temperature sensitive mutant, Veterinary Record 114, 1983, 353–354. - PubMed
-
- Cocker F.M., Newby T.J., Gaskell R.M., Evans P.A., Gaskell C.J., Stokes C.R., Harbour D.A., Bourne J.F. Responses of kittens to nasal vaccination with a live, modified feline herpesvirus type 1, Research in Veterinary Science 41, 1986, 323–330. - PubMed
-
- Davis E.V., Beckenhauer W.H. Studies on the safety and efficacy of an intranasal feline rhinotracheitis-calicivirus vaccine, Veterinary Medicine for the small Animal Clinician 71, 1976, 1405–1410. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources